127 related articles for article (PubMed ID: 20112043)
1. 14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer.
Zang D; Li X; Zhang L
Clin Exp Med; 2010 Dec; 10(4):221-8. PubMed ID: 20112043
[TBL] [Abstract][Full Text] [Related]
2. The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell lung cancer progression.
Zhao GY; Ding JY; Lu CL; Lin ZW; Guo J
Cancer; 2014 Mar; 120(5):652-63. PubMed ID: 24804299
[TBL] [Abstract][Full Text] [Related]
3. Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer.
Zhou ZY; Yang GY; Zhou J; Yu MH
J Chin Med Assoc; 2012 Jun; 75(6):269-74. PubMed ID: 22721621
[TBL] [Abstract][Full Text] [Related]
4. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer.
Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH
Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of β-catenin and matrix metalloproteinase-2 expression in non-small cell lung cancer.
Li GH; Cui YS; Wu QY; Zhang XJ; Gao YF
Med Oncol; 2013 Mar; 30(1):437. PubMed ID: 23292837
[TBL] [Abstract][Full Text] [Related]
7. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
9. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
Tong L; Wu W
Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
[TBL] [Abstract][Full Text] [Related]
10. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E
Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
[TBL] [Abstract][Full Text] [Related]
13. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
[TBL] [Abstract][Full Text] [Related]
14. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
15. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327
[TBL] [Abstract][Full Text] [Related]
16. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of 14-3-3zeta is an early event in oral cancer.
Matta A; Bahadur S; Duggal R; Gupta SD; Ralhan R
BMC Cancer; 2007 Sep; 7():169. PubMed ID: 17764575
[TBL] [Abstract][Full Text] [Related]
19. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.
Che J; Yang Y; Xiao J; Zhao P; Yan B; Dong S; Cao B
Tumour Biol; 2015 Aug; 36(8):6559-68. PubMed ID: 25820701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
